262 related articles for article (PubMed ID: 22427255)
1. CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis.
Ouellet V; Siegel PM
J Cell Commun Signal; 2012 Jun; 6(2):73-85. PubMed ID: 22427255
[TBL] [Abstract][Full Text] [Related]
2. CCN3 and calcium signaling.
Lombet A; Planque N; Bleau AM; Li CL; Perbal B
Cell Commun Signal; 2003 Aug; 1(1):1. PubMed ID: 14606958
[TBL] [Abstract][Full Text] [Related]
3. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
4. The regulation and functions of the matricellular CCN proteins induced by shear stress.
Wang YK; Weng HK; Mo FE
J Cell Commun Signal; 2023 Jun; 17(2):361-370. PubMed ID: 37191841
[TBL] [Abstract][Full Text] [Related]
5. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
[TBL] [Abstract][Full Text] [Related]
6. CCN3--a key regulator of the hematopoietic compartment.
McCallum L; Irvine AE
Blood Rev; 2009 Mar; 23(2):79-85. PubMed ID: 18752874
[TBL] [Abstract][Full Text] [Related]
7. The expression of ccn3(nov) gene in musculoskeletal tumors.
Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
[TBL] [Abstract][Full Text] [Related]
8. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
[TBL] [Abstract][Full Text] [Related]
9. CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.
Ouellet V; Tiedemann K; Mourskaia A; Fong JE; Tran-Thanh D; Amir E; Clemons M; Perbal B; Komarova SV; Siegel PM
Am J Pathol; 2011 May; 178(5):2377-88. PubMed ID: 21514448
[TBL] [Abstract][Full Text] [Related]
10. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.
Minamizato T; Sakamoto K; Liu T; Kokubo H; Katsube K; Perbal B; Nakamura S; Yamaguchi A
Biochem Biophys Res Commun; 2007 Mar; 354(2):567-73. PubMed ID: 17250806
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Roles of CCN3 Protein in Immune-Related Diseases.
Peng L; Wei Y; Shao Y; Li Y; Liu N; Duan L
Mediators Inflamm; 2021; 2021():5576059. PubMed ID: 34393649
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
13. Biological characteristics of CCN proteins in tumor development.
Barreto SC; Ray A; Ag Edgar P
J BUON; 2016; 21(6):1359-1367. PubMed ID: 28039692
[TBL] [Abstract][Full Text] [Related]
14. CCN1 (CYR61) and CCN3 (NOV) signaling drives human trophoblast cells into senescence and stimulates migration properties.
Kipkeew F; Kirsch M; Klein D; Wuelling M; Winterhager E; Gellhaus A
Cell Adh Migr; 2016 Mar; 10(1-2):163-78. PubMed ID: 26744771
[TBL] [Abstract][Full Text] [Related]
15. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
Chen PC; Cheng HC; Tang CH
Carcinogenesis; 2013 Jul; 34(7):1669-79. PubMed ID: 23536580
[TBL] [Abstract][Full Text] [Related]
16. A friend in knee: CCN3 may inhibit osteoarthritis progression.
Peidl A
J Cell Commun Signal; 2018 Jun; 12(2):489-490. PubMed ID: 29332174
[TBL] [Abstract][Full Text] [Related]
17. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
18. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
[TBL] [Abstract][Full Text] [Related]
19. CCN3 increases BMP-4 expression and bone mineralization in osteoblasts.
Tan TW; Huang YL; Chang JT; Lin JJ; Fong YC; Kuo CC; Tsai CH; Chen YJ; Hsu HC; Cho DY; Chen YH; Tang CH
J Cell Physiol; 2012 Jun; 227(6):2531-41. PubMed ID: 21898398
[TBL] [Abstract][Full Text] [Related]
20. Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways.
Kawaki H; Kubota S; Suzuki A; Suzuki M; Kohsaka K; Hoshi K; Fujii T; Lazar N; Ohgawara T; Maeda T; Perbal B; Takano-Yamamoto T; Takigawa M
Bone; 2011 Nov; 49(5):975-89. PubMed ID: 21763478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
